Real-time management of chemotherapy toxicity using the Advanced Symptom Management System (ASyMS)

This paper describes an ongoing study of the Advanced Symptom Management System (ASyMS) for patients receiving chemotherapy for breast or colorectal cancer. We begin by detailing the ASyMS work to date, providing an overview of research conducted in the field over the last ten years. The current study, ASyMS-III, is then presented, highlighting the study methodology, multi-site involvement, the outcomes being measured, and discussion of the tool. The paper concludes with reflections on the progress of the ASyMS-III study to date, and discusses potential directions for future research.

[1]  N. Kearney,et al.  Evaluation of a mobile phone-based, advanced symptom management system (ASyMS©) in the management of chemotherapy-related toxicity , 2009, Supportive Care in Cancer.

[2]  N. Kearney,et al.  Patients ’ perceptions and experiences of using a mobile phone-based advanced symptom management system ( ASyMS © ) to monitor and manage chemotherapy related toxicity , 2009 .

[3]  N. Kearney,et al.  The development of a side effect risk assessment tool (ASyMS©-SERAT) for use in patients with breast cancer undergoing adjuvant chemotherapy , 2009 .

[4]  A. Louis,et al.  A systematic review of telemonitoring for the management of heart failure , 2003, European journal of heart failure.

[5]  N. Kawakami,et al.  The Job Content Questionnaire (JCQ): an instrument for internationally comparative assessments of psychosocial job characteristics. , 1998, Journal of occupational health psychology.

[6]  G. Lyman,et al.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients , 2006, Cancer.

[7]  M. Litt,et al.  Ecological momentary assessment (EMA) with treated alcoholics: methodological problems and potential solutions. , 1998, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[8]  J. Grossman,et al.  The Randomized Controlled Trial: gold standard, or merely standard? , 2005, Perspectives in biology and medicine.

[9]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  N. Kearney,et al.  Results of a UK based pilot study of a mobile phone based advanced symptom management system (ASyMS) in the remote monitoring of chemotherapy related toxicity , 2005 .

[11]  Lisa C Richardson,et al.  Remote patient–provider communication and quality of life: empirical test of a dialogic model of cancer care , 2007, Journal of telemedicine and telecare.

[12]  E. Ream,et al.  The experience of fatigue and other symptoms in patients receiving chemotherapy. , 1996, European journal of cancer care.

[13]  N. Kearney,et al.  Nurse's perceptions and experiences of using of a mobile-phone-based Advanced Symptom Management System (ASyMS) to monitor and manage chemotherapy-related toxicity. , 2008, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[14]  Xianglin L. Du,et al.  Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Owen,et al.  A measure of self-care self-efficacy. , 1996, Research in nursing & health.

[16]  A. Abernethy,et al.  Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. , 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

[17]  R. Rabin,et al.  EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.

[18]  B. Murphy.  Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. , 2007, The journal of supportive oncology.

[19]  R. Sanderman.  Measuring the quality of life of cancer patients with the Rotterdam Symptom Checklist (RSCL): a manual , 1996 .

[20]  Paul Turner,et al.  Patients at the Centre: Methodological Considerations for Evaluating Evidence from Health Interventions Involving Patients Use of Web-Based Information Systems , 2010, The open medical informatics journal.

[21]  C. Masella,et al.  Systematic review of telemedicine services for patients affected by chronic obstructive pulmonary disease (COPD). , 2009, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[22]  R. Sanson-Fisher,et al.  Reducing the unmet needs of patients with colorectal cancer: a feasibility study of The Pathfinder Volunteer Program , 2007, Supportive Care in Cancer.

[23]  D. Cella,et al.  The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT‐G) in patients with primary brain tumors , 1995, Cancer.

[24]  Neha Dixit,et al.  Healthcare Utilization Among Veterans Undergoing Chemotherapy: The Impact of a Cancer Care Coordination/Home‐Telehealth Program , 2007, The Journal of ambulatory care management.

[25]  S. Silverman.  Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. , 2007 .

[26]  J. Siegrist.  Adverse health effects of high-effort/low-reward conditions. , 1996, Journal of occupational health psychology.

[27]  Meurig Sage,et al.  Perceptions of the use of a remote monitoring system in patients receiving palliative care at home. , 2008, International journal of palliative nursing.

[28]  Faith Gibson,et al.  Utilization of the Medical Research Council Evaluation Framework in the Development of Technology for Symptom Management: The ASyMS©-YG Study , 2010, Cancer nursing.

[29]  Evidence-Based Alternative Medicine? , 2005, Perspectives in biology and medicine.

[30]  C. Anandan,et al.  The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview , 2011, PLoS medicine.

[31]  Robyn Bluhm,et al.  From Hierarchy to Network: a richer view of evidence for evidence-based medicine , 2005, Perspectives in biology and medicine.

[32]  R. Beyth,et al.  The effectiveness of a care coordination home telehealth program for veterans with diabetes mellitus: a 2-year follow-up. , 2006, The American journal of managed care.

[33]  N. Kearney,et al.  Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study , 2006, Supportive Care in Cancer.

[34]  Julie Cowie,et al.  ASYMS-SERAT: A Side-Effect Risk Assessment Tool to Predict Chemotherapy Related Toxicity in Patients with Cancer Receiving Chemotherapy , 2008, HEALTHINF.

[35]  S. Timmermans.  From Autonomy to Accountability: the role of clinical practice guidelines in professional power , 2005, Perspectives in biology and medicine.

[36]  R. Sanson-Fisher,et al.  Does routine assessment and real-time feedback improve cancer patients' psychosocial well-being? , 2006, European journal of cancer care.

[37]  N. Chumbler,et al.  Evaluation of a Care Coordination/Home-Telehealth Program for Veterans with Diabetes , 2005, Evaluation & the health professions.

[38]  A. Rigby,et al.  Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. , 2005, Journal of the American College of Cardiology.

[39]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[40]  Vibeke Backer,et al.  Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. , 2005, The Journal of allergy and clinical immunology.

[41]  Graham Thornicroft,et al.  Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations , 2011, PLoS medicine.